Practical neonatal endocrinology

Practical Neonatal Endocrinology

Volumn 9780521838498, Issue , 2006, Pages 1-218

  Ogilvy Stuart, Amanda ^a   Midgley, Paula ^b  

^a Rosie Maternity Hospital   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84925056993     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511544736     Document Type: Book

References (157)

1. Bolt RJ, von Weissenbruch MM, Lafeber HN, et al.Evaluation of low-dose ACTH stimulation tests in preterm infants with a gestational age below 33 weeks. Horm Res1999; 51 (Suppl 2); 69 (abstract).
2. Bolt RJ, van Weissenbruch MM, Cranenonk A, et al. The corticotrophin-releasing hormone test in preterm infants. Clin Endocrinol (Oxf)2002; 56: 207–213.
3. Chanoine JP, Rebuffat E, Kahn A, et al. Glucose, growth hormone, cortisol, and insulin responses to glucagon injection in normal infants, aged 0.5–12 months. J Clin Endocrinol Metab1995; 80: 3032–3035.
4. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab2000; 85: 3990–3993.
5. Crofton PM and Midgley PC. Cortisol and growth hormone responses to spontaneous hypoglycaemia in infants and children. Arch Dis Child2004; 89: 472–478.
6. Hingre RV, Gross SJ, Hingre KS, et al. Adrenal steroidogenesis in very low birth weight preterm babies. J Clin Endocrinol Metab1994; 78: 266–270.
7. Karlsson R, Kallio J, Irjala K, et al. Adrenocorticotrophin and corticotrophin-releasing hormone tests in preterm infants. J Clin Endocrinol Metab2000; 85: 4592–4595.
8. Korte C, Styne D, Merritt TA, et al. Adrenocortical function in the very low birth weight infant: improved testing sensitivity and association with neonatal outcome. J Pediatr1996; 128: 257–263.
9. Ng PC, Wong GW, Lam CW, et al. The pituitary-adrenal responses to exogenous human corticotrophin-releasing hormone in preterm, very low birth weight infants. J Clin Endocrinol Metab1997; 82: 797–799.
10. Ng PC, Lam WK, Lee CH, et al. Reference ranges and factors affecting the human corticotrophin-releasing hormone test in preterm, very low birth weight infants. J Clin Endocrinol Metab2002; 87: 4621–4628.
11. Walker JM, Hughes IA. Tests and normal values in paediatric endocrinology, In Clinical Paediatric Endocrinology, third edition, Chapter 40, Ed. Brook CGD. Blackwell Science: Oxford, 1995, pp. 782–798.
12. Adams LM, Emery JR, Clark SJ, et al. Reference ranges for newer thyroid function tests in premature infants. J Pediatr1995; 126: 122.
13. Arnold J, Leslie G, Bowen J, Watters S. Longitudinal study of plasma cortisol and 17-hydroxyprogesterone in very low birth weight infants during the first 16 weeks of life. Biol Neonate1997; 72: 148–155.
14. Bamforth JR. Serum free thyroxine and free triiodothyronine concentrations in healthy full term, pre-term and sic pre-term neonates. Annals of Clin Biochem1987; 24: 461–465.
15. Bergada I, Milani C, Bedecarras P, et al. Time course or the gonadotrophin surge, inhibins and antimullerian hormone (AMH) in normal newborn males in the first month of life 2005. Horm Res64 (Suppl 1); OR10-114:33.
16. Bolt RJ, Van Wiessenbruch MM, Popp-Snijders C, et al. Maturity of the adrenal cortex in very preterm infants is related to gestational age. Pediatr Res2002; 52: 405–410.
17. Cacclari E, Cicognani A, Pirazzoli P, et al. Plasma ACTH values during the first seven days of life in infants of diabetic mothers. J Pediatr1975; 87 (6): 943–945.
18. Cacclari E, Cicognani A, Pirazoli P, et al. GH, ACTH, LH and FSH behaviour in the first seven days of life. Acta Paediatr Scand1976; 65: 337.
19. Cuestas RA. Thyroid function in preterm infants. J Pediatr1979; 92: 963–967.
20. de Peretti E, Forest MG. Unconjugated dehydroepiandrosterone plasma levels in normal subjects from birth to adolescence in human: the use of a sensitive radioimmunoassay. J Clin Endocrinol Metab1976; 43 (5): 982–991.
21. de Peretti E, Forest MG. Pattern of plasma dehydroepiandrosterone sulfate levels in humans from birth to adulthood: evidence for testicular production. J Clin Endocrinol Metab1978; 47 (3): 572–577.
22. Dillon MJ, Ryness JM. Plasma rennin activity and aldosterone concentrations in children. Br Med J1975; 4: 316.
23. Dorr HG, Sippell WG, Versmold HT, et al. Plasma aldosterone and 11-deoxycortisol in term neonates: a re-evaluation. J Clin Endocrinol Metab1987; 65: 208–210.
24. Fisher DA. Thyroid function tests in premature infants. The hypothyroxinaemia of prematurity. Clin Perinatol1998; 25: 999–1014.
25. Forest MG, Bertrand J. Sexual steroids in neonatal period. Abstracts of the 7th congress of the international study group for steroids. Biochem 1975: 6: xxxiv.
26. Guyda HJ, Friesen HG. Serum prolactin levels in humans from birth to adult life. Pediatr Res1973; 7: 534.
27. Heckmann M, Wudy SA, Haack D, Pohlandt F. Serum cortisol concentrations in ill preterm infants less than 30 weeks gestational age. Acta PaediatrSeptember 2000; 89 (9): 1098.-103.89:1098–1103.
28. Hesse V, Partsch CJ, Ulmen U, et al. What's the difference in male and female babies from a hormonal point of view in the first 5 months of life. Horm Res2005; 64 (Suppl 1); OR5-83:24.
29. Hillman LS, Rojanasathit, Slatopolskye, Haddad JG. Serial measurements of serum calcium, magnesium, parathyroid hormone, calcitonin and 25-hydroxy-vitamin D in premature and term infants during the first week of life. Pediatr Res1977; 7: 534.
30. Kari MA, Raivio KO, Stenman U, Vouitilainen R. Serum cortisol, dehydroepiandrosterone sulfate, and steroid-binding globulins in preterm neonates: effect of gestational age and dexamethasone therapy. Pediatr Res1996; 40: 319–324.
31. Kojima S, Yanaihara T, Nakayama T. Serum steroid levels in children at birth and in early neonatal period. Am J Obstet Gynecol1981; 140: 961–965.
32. Kraiem Z, Sack J, Brish M. Serum cortisol levels: the first 10 days in full-term and preterm infants. Israel J Med Sci1985; 21: 170–172.
33. Kruse K. Renal threshold phosphate concentration. Arch Dis Child1982; 57: 217–223.
34. Lee MM, Rajagopalan L, Berk GJ, Moshang Jr T. Serum adrenal steroid concentrations in preterm infants 1989. J Clin Endocrinol Metab1989; 69: 1133–1136.
35. LeRoith D, Butler AA. Insulin-like growth factors in pediatric health and disease. J Clin Endocrinol Metab1999; 84: 4355.
36. Lo MS, Ng ML, Wu LL, Khalid BA. Measurement of androstenedione levels by an in-house radioimmunoassay. Malays J Pathol1996; 18: 53–58.
37. Midgley PC, Russell K, Oates N, et al. Adrenal function in preterm infants: ACTH may not be the sole regulator of the fetal zone. Pediatr Res1998; 44: 887–893.
38. Midgley PC, Holownia P, Smith J, et al. Plasma cortisol, cortisone and urinary glucocorticoid metabolites in preterm infants. Biol Neonate2001; 79: 79–86.
39. Neely EK, Hintz RL, Wilson DM, et al. Normal ranges for immunohistochemiluminometric gonadotrophin assays. J Pediatr1995; 127: 40–46.
40. Nelson JC, Clark SJ, Borot DL, et al. Age related changes in serum free thyroxine during childhood and adolescence. J Pediatr1993; 123: 899–905.
41. Ng PC, Wong GW, Lam CW, et al. The pituitary-adrenal responses to exogenous human corticotrophin-releasing hormone in preterm, very low birth weight infants. J Clin Endocrinol Metab1997; 82: 797–799.
42. Ng PC, Lam WK, Lee CH, Ma KC, et al. Reference ranges and factors affecting the human corticotrophin-releasing hormone test in preterm, very low birth weight infants. J Clin Endocrinol Metab2002; 87: 4621–4628.
43. Sippell WG, Becker H, Versmold HT, et al. Longitudinal studies of plasma aldosterone corticosterone, deoxycorticosterone, progesterone, 17-hydroxyprogesterone, cortisol, and cortisone determined simultaneously in mother and child at birth and during the early neonatal period. I. Spontaneous delivery. J Clin Endocrinol Metab1978; 46: 971–985.
44. Stark P, Beckerhoff R, Leumann EP, et al. Control of plasma aldosterone in infancy and childhood. Helv Paediatr Acta1975; 30: 349.
45. Styne DM. The testes: disorders of sexual differentiation and puberty in the male. In Pediatric Endocrinology, Ed. Sperling MA. WB Saunders, Philidelphia, 2002, pp. 565–628.
46. Tapanainen J, Koivisto M, Vihko R, et al. Enhanced activity of the pituitary-gonadal axis in premature human infants. J Clin Endocrinol Metab1981; 52: 235.
47. Walton RJ. Normogram for derivation of renal threshold phosphate concentration. Lancet1975; 2: 57: 217–223.
48. Winter JSD, Hughes IA, Reyes FI, et al. Pituitary-gonadal relations in infancy: II: patterns of serum gonadal steroid concentrations in man from birth to two years of age. J Clin Endocrinol Metab1976; 42: 679.
49. Hawdon JM, Aynsley-Green A. Disorders of blood glucose homeostasis in the neonate. In Textbook of Neonatology, third edition, Eds. Rennie JM, Roberton NRC. Churchill Livingstone, pp. 939–956.
50. Polak M, Shield J. Neonatal and very-early-onset diabetes mellitus. Semin Neonatol2004; 9: 59–65 (review).
51. Hume R, Burchell A, Williams FL, Koh DK. Glucose homeostasis in the newborn. Early Hum Dev2005; 81: 95–101.
52. Hey E. Hyperglycaemia and the very preterm baby. Semin Fetal Neonatal Med2005; 10: 377–387.
53. Lee PJ, Leonard JV. Hypoglycaemia. In Clinical Paediatric Endocrinology, third edition, Ed. Brook CGD. pp. 677–693.
54. Hawdon JM, Aynsley-Green A. Disorders of blood glucose homeostasis in the neonate. In Textbook of Neonatology, third edition, Eds. Rennie JM, Roberton NRC. Churchill Livingstone, pp. 939–956.
55. Hawdon JM, Weddell A, Aynsley-Green A, Ward Platt MP. Hormonal and metabolic response to hypoglycaemia in small for gestational age infants. Arch Dis Child1993; 68: 269–273.
56. Bazaes RA, Salazar TE, Pittaluga, et al. Glucose and lipid metabolism in small for gestational age infants at 48 hours of age. Pediatrics2003; 111: 804–809.
57. Koh TH, Aynsley-Green A, Tarbit M, Eyre JA. Neural dysfunction during hypoglycaemia. Arch Dis Child1988; 63: 1353–1358.
58. Lucas A, Morley R, Cole TJ. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. Br Med J1988; 297: 1303–1308.
59. de Rooy L, Hawdon J. Nutritional factors that affect the postnatal metabolic adaptation of full-term small- and large-for-gestational-age infants. Pediatrics2002; 109: e42.
60. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. New Engl J Med2001; 345: 1359–1367.
61. Stanley CA, Thornton PS, Finegold DN, Sperling MA. Hypoglycemia in neonates and infants. In Pediatric Endocrinology, second edition, Ed. Sperling MA. Saunders, pp. 135–159.
62. Cornblath M, Hawdon JM, Williams AF, et al. Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds. Pediatrics2000; 105: 1141–1145.
63. Cornblath M, Hawdon JM, Williams AF, et al. Arch Dis Child Fetal NeonatolEd 2000; 82: F79–F97 provides a series of related articles.
64. Hussain K. Congenital hyperinsulinism. Semin Fetal Neonatal Med2005 August; 10: 369–376.
65. Hardy O, Wanner L, O’Rourke S, et al. Focal lesions in congenital hyperinsulinism localized using [18F]-fluorodopa PET scan. Horm Res2005; 64 (Suppl 1): P3-1262, p. 366.
66. Blankenstein O, Monhnike W, Fuechtner F, Mohnike K, Grueters A. Combined 18Fluoro-L-Dopa-PET/CT as a tool for localization diagnostic in patients with congenital hyperinsulinism. Horm Res2005; 64 (Suppl 1): P3-1260, p. 365.
67. Hussain K, Smith V, Pierro A. The laparoscopic approach to the management of congenital hyperinsulinism of infancy. Horm Res2005; 64 (Suppl 1): P3-1263, p. 366.
68. Walker R, Jack M, Greer R, Brown D, Bowling F, Cowley D, Bell J, Cotterill A. Role of histology in planning definitive surgery in patients with hyperinsulinism of infancy. Horm Res2005; 64 (Suppl 1): P3-1264, pp. 366–367.
69. Hawdon JM, Aynsley-Green A. Disorders of blood glucose homeostasis in the neonate. In Textbook of Neonatology, third edition, Eds. Rennie JM, Roberton NRC, Churchill Livingstone. pp. 939–956.
70. Lee PJ, Leonard JV. Hypoglycaemia. In Clinical Paediatric Endocrinology, third edition, Ed. Brook CGD. pp. 678–693.
71. Ward Platt M, Deshpande S. Metabolic adaptation at birth. Semin Fetal Neonatal Med2005; 10: 341–350.
72. Deshpande S, Ward Platt M. The investigation and management of neonatal hypoglycaemia. Semin Fetal Neonatal Med2005; 10: 351–361.
73. Beckwith-Wiedemann Support Network: www. beckwith-wiedemann.org
74. Beckwith-Wiedemann Support Group: www.bws_support.org.uk
75. Contact a Family (UK): www.cafamily.org.uk
76. Laurence-Moon-Bardet-Biedl Society: www.lmbbs.org.uk
77. Max appeal: www.maxappeal.org.uk
78. National Organization for Rare Disorders (US): www.rarediseases.org
79. Prader-Willi Syndrome Association (UK): www.pwsa.co.uk
80. The 22q11 Group: www.vcfs.net
81. The Pituitary Foundation: www.pituitary.org.uk
82. Unique – The Rare Chromosome Disorder Support Group: www.rarechromo.org
83. Velo-Cardio-Facial Syndrome Education Foundation: www.vcfsef.org
84. Charmandari E, Dattani MT, Perry LA, et al. Kinetics and effect of percutaneous administration of dihydrotestosterone in children. Horm Res2001; 56: 177–181.
85. Cheng PK, Chanoine JP. Should the definition of micropenis vary according to ethnicity? Horm Res2001; 55: 278–281.
86. Ludwig G. Micropenis and apparent micropenis – a diagnostic and therapeutic challenge. Andrologia1999; 31 (Suppl 1): 27–30 (review).
87. Tuladhar R, Davis PG, Batch J, Doyle LW. Establishment of a normal range of penile length in preterm infants. J Paediatr Child Health1998; 34: 471–473.
88. The pituitary Foundation: www.pituitary.org.uk
89. Serono booklet: Emergency Information Pack for Children with Cortisol and GH Deficiencies and those Experiencing Recurrent Hypoglycaemia: www.bsped.org.uk/patients/serono/05_EmergencyInformationPack.pdf
90. Ahmed SF, Khwaja O, Hughes IA. The role of a clinical score in the assessment of ambiguous genitalia. Br J Urol Int2000; 85: 120–124.
91. Anhalt H, Neely EK, Hintz RL. Ambiguous genitalia. Pediatr Rev1996; 17: 213–220.
92. Ogilvy-Stuart AL, Brain CE. Early assessment of ambiguous genitalia. Arch Dis Child2004; 89: 401–407.
93. Feldman Witchel S, Lee PA. Ambiguous genitalia. In Pediatric Endocrinology, second edition, Ed. Sperling MA. Saunders. pp. 111–133.
94. Sultan C, Paris F, Jeandel C, et al. Ambiguous genitalia in the newborn. Semin Reprod Med2002; 20: 181–188.
95. Warne GL, Hughes IA. The clinical management of ambiguous genitalia. In Clinical Paediatric Endocrinology, third edition, Ed. Brook CGD. Blackwell. pp. 53–68.
96. Kolon TF, Patel RP, Huff DS. Cryptorchidism: diagnosis, treatment, and long-term prognosis. Urol Clin North Am2004; 31: 469–480, viii–ix.
97. Lee PA. Fertility in cryptorchidism. Does treatment make a difference? Endocrinol Metab Clin North Am1993; 22; 479–490.
98. Leung AK, Robson WL. Current status of cryptorchidism. Adv Pediatr2004; 51: 351–377.
99. Swerdlow AJ, Higgins CD, Pike MC. Risk of testicular cancer in cohort of boys with cryptorchidism. Br Med J1997; 314: 1507–1511.
100. Ahmed SF, Hughes IA. The genetics of male undermasulinization. Clin Endocrinol2002; 56: 1–18.
101. Rosenfield RL. Puberty in the female and its disorders. In Pediatric Endocrinology, second edition, Ed. Sperling MA. Saunders. pp. 455–453.
102. Styne DM. The testes. In Pediatric Endocrinology, second edition, Ed. Sperling MA. Saunders. pp. 565–628.
103. Vainio S, Heikkila M, Kispert A, Chin N, McMahon AP. Female development in mammals is regulated by Wnt-4 signalling. Nature1999; 379: 707–710.
104. Achermann JC, Meeks JJ, Jameson JL. Phenotypic spectrum of mutations in DAX-1 and SF-1. Mol Cell Endocrinol2001; 185: 17–25.
105. Cummings JJ, D’Eugenio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk of bronchopulmonary dysplasia. New Engl J Med1989; 320: 1505–1510.
106. Kidd S, Midgley P, Nicol M, et al. Lack of adult type Circadian rhythm in hospitalized preterm infants. Horm Res2005; 64: 20–27.
107. Kojima S, Yanaihara T, Nakayama T. Serum steroid levels in children at birth and in early neonatal period. Am J Obstet Gynecol1981; 140: 961–965.
108. Mesiano S, Jaffe RB. Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev1997; 18: 378–403.
109. Metzger DL, Wright NM, Veldhuis JD, et al. Characterization of pulsatile secretion and clearance of plasma cortisol in premature and term neonates using deconvolution analysis. J Clin Endocrinol Metab1993; 77: 458–463.
110. Midgley PC, Russell K, Oates N, et al. Adrenal function in preterm infants: ACTH may not be the sole regulator of the fetal zone. Pediatr Res1998; 44: 887–893.
111. Ng PC. The fetal and neonatal hypothalamic–pituitary–adrenal axis. Arch Dis Child Fetal Neonatal Ed2000; 82: F25025-4.
112. Santiago LB, Jorge SM, Moriera AC. Longitudinal evaluation of the development of salivary cortisol cirdcadian rhythm in infancy. Clin Endocrinol1996; 44: 157–161.
113. Sippell WG, Dorr HG, Becker H, et al. Simultaneous determination of seven unconjugated steroids in maternal venous and umbilical arterial and venous serum in elective and emergency Cesarian section at term. Am J Obstet Gynecol1979; 135: 530–542.
114. Watterberg KL, Scott SM. Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia. Pediatrics1995; 95: 120–125.
115. Yeh TF, Yuh JL, Huang JC, et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics1998; 101.
116. Cunningham S, Symon AG, Elton RA, et al. Intra-arterial blood pressure reference ranges, death and morbidity in very low birth weight infants during the first seven days of life. Early Hum Dev1999; 56: 151–165.
117. Ng PC, Lee CH, Lam CW, et al. Transient adrenocortical insufficiency of prematurity and systemic hypotension in VLBW infants. Arch Dis Child Fetal Neonatal Ed2004; 89: F119–F126.
118. Arad I, Landau H. Adrenocortical reserve of neonates born of long-term steroidtreated mothers. Eur J Pediatr1984; 142: 279–280.
119. Arnold JD, Bonacruz G, Leslie GI, et al. Antenatal glucocorticoids modulate the amplitude of pulsatile cortisol secretion in premature neonates. Pediatr Res1998; 44: 876–881.
120. Banks BA, Cnaan A, Morgan MA, et al. Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotrophin-Releasing Hormone Study Group. Am J Obstet Gynecol1999; 181: 709–717.
121. Bongiovanni AM, McPadden AJ. Steroids during pregnancy and possible fetal consequences. Fertil Steril1960; 11: 181–186.
122. Buescher MA, McClamrock HD, Adashi EI. Cushing syndrome in pregnancy. Obstet Gynecol1992; 79: 130–137.
123. Demarini S, Dollberg S, Hoath SB, et al. Effects of antenatal corticosteroids on blood pressure in very low birth weight infants during the first 24 hours of life. J Perinatol1999; 19: 419–425.
124. Edwards HE, Burnham WM. The impact of corticosteroids on the developing animal. Pediatr Res2001; 50: 433–440.
125. French NP, Hagan R, Evans SF, et al. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol1999; 180: 114–121.
126. French NP, Hagan R, Evans SF, Mullan A, Newnham JP. Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior. Am J Obstet Gynecol2004; 190: 588–595.
127. Kasperlik-Zaluska AA, Szczupacka I, Leszczynska-Bystrzanowska J, et al. Pregnancydependent Cushing's syndrome in three pregnancies. Br J Obstet Gynaecol2000; 107: 810–812.
128. Ng PC, Wong GWK, Lam CWK, et al. Effect of multiple courses of antenatal corticosteroids on pituitary–adrenal function in preterm infants. Arch Dis Child Fetal Neonatal Ed1999; 80: F213–F216.
129. Reinisch JM, Simon SG, Karow WG, et al. Prenatal exposure to prednisolone in humans and animals retards intrauterine growth. Science1978; 202: 436–438.
130. Uno H, Lohmiller L, Thieme C, et al. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Dev Brain Res1990; 53: 157–167.
131. Diamond FB, Root AW. Disorders of calcium metabolism in the newborn and infant. In Pediatric Endocrinology, second edition, Ed. Sperling MA. Saunders. pp. 97–110.
132. Hsu SC, Levine MA. Perinatal calcium metabolism: physiology and pathophysiology. Semin Neonatol2004; 9 (1): 23–36.
133. Kruse K. Disorders of calcium and bone metabolism. In Clinical Paediatric Endocrinology, third edition, Ed. Brook CGD. Blackwell. pp. 735–778.
134. Diamond FB, Root AW. Disorders of calcium metabolism in the newborn and infant. In Pediatric Endocrinology, second edition, Ed. Sperling MA. Saunders. pp. 97–110.
135. Hsu SC, Levine MA. Perinatal calcium metabolism: physiology and pathophysiology. Semin Neonatol2004; 9 (1): 23–36.
136. Kruse K. Endocrine control of calcium and bone metabolism. In Clinical Paediatric Endocrinology, third edition, Ed. Brook CGD. Blackwell. pp. 713–734.
137. Beardsall K, Ogilvy-Stuart AL. Congenital hypothyroidism. Curr Paediatr2004; 14: 422–429.
138. Fisher DA. Disorders of the thyroid in the newborn and infant. In Pediatric Endocrinology, second edition, Ed. Sperling MA. Saunders, pp. 97–110, 161–185.
139. Foulds N, Walpole I, Elmslie F, Mansour S. Carbimazole embryopathy: an emerging phenotype. Am J Med Genet A2005; 132: 130–135.
140. Gruters A, Biebermann H, Krude H. Neonatal thyroid disorders. Horm Res2003; 59 (Suppl 1): 24–29.
141. Gruters A, Krude H, Biebermann H. Molecular genetic defects in congenital hypothyroidism. Eur J Endocrinol2004; 151 (Suppl 3): U39–U44.
142. Ogilvy-Stuart AL. Neonatal thyroid disorders. Arch Dis Child Fetal Neonatal Ed2002; 87: F165–F171.
143. Polak M. Hyperthyroidism in early infancy: pathogenesis, clinical features and diagnosis with a focus on neonatal hyperthyroidism. Thyroid1998; 8: 1171–1177.
144. Radetti G, Zavallone A, Gentili L, Beck-Peccoz P, Bona G. Fetal and neonatal thyroid disorders. Minerva Pediatr2002; 54: 383–400.
145. Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid1999; 9: 727–733.
146. Beardsall K, Ogilvy-Stuart AL. Congenital hypothyroidism. Curr Paediatr2004; 14: 422–429.
147. Ogilvy-Stuart AL. Neonatal thyroid disorders. Arch Dis Child Fetal Neonatal Ed2002; 87: F165–F171.
148. Beardsall K, Ogilvy-Stuart AL. Congenital hypothyroidism. Curr Paediatr2004; 14: 422–429.
149. Cody D, Kumar Y, Ng SM, Didi M, Smith C. The differing outcomes of hyperthyrotrophinaemia. J Pediatr Endocrinol Metab2003; 16: 375–378.
150. Daliva AL, Linder B, DiMartino-Nardi J, Saenger P. Three-year follow-up of borderline congenital hypothyroidism. J Pediatr2000; 136: 53–56.
151. Fisher DA. Disorders of the thyroid in the newborn and infant. In Pediatric Endocrinology, second edition, Ed. Sperling MA. Saunders. pp. 97–110; 161–185.
152. Gruters A, Biebermann H, Krude H. Neonatal thyroid disorders. Horm Res2003; 59 (Suppl 1): 24–29.
153. Heyerdahl S, Oerbeck B. Congenital hypothyroidism: developmental outcome in relation to levothyroxine treatment variables. Thyroid2003; 13: 1029–1038.
154. Van Vliet G. Treatment of congenital hypothyroidism. Lancet2001 July 14; 358: 86–87.
155. Fisher DA. Disorders of the thyroid in the newborn and infant. In Pediatric Endocrinology, second edition, Ed. Sperling MA. Saunders. pp. 97–110, 161–185.
156. Rapaport R, Rose SR, Freemark M. Hypothroxinaemia in the preterm infant: the benefits and risks of thyroxine treatment. J Pediatr2001; 139: 182–188.
157. Van Wassenaer AG, Kok JH, de Vijlder JJ, et al. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks’ gestation. New Engl J Med1997; 42: 87–92.